Cantor Fitzgerald Maintains Overweight on Eli Lilly, Raises Price Target to $550
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen maintains an Overweight rating on Eli Lilly (NYSE:LLY) and raises the price target from $485 to $550.
June 27, 2023 | 4:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald has maintained an Overweight rating on Eli Lilly and raised the price target from $485 to $550, indicating a positive outlook for the company.
The raised price target by Cantor Fitzgerald indicates a positive outlook for Eli Lilly. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100